The Division of Medical Oncology is a member of the Department of Medicine at The Ottawa Hospital and the University of Ottawa Faculty of Medicine. The Division provides all medical oncology services to Eastern Ontario with a population of over 1.2 million.
There are currently 19 full time medical oncologists supported by allied health professionals in tumour site specific teams. The Division has a leading role in conducting local, national and international clinical trials in association with the Ottawa Health Research Institute. The Division also fulfills its academic role through undergraduate, postgraduate and continuing medical education activities.
The Division is a leader in education in the undergraduate, postgraduate and accredited continuing medical education. Our division can provide a comprehensive experience in leading edge care in multidisciplinary tumour sites including novel therapies through clinical trials.
We can offer encounters in both the inpatient and outpatient settings as well as through the Women’s Breast Health Centre and Ontario Breast Screening Project.
Research in the Division of Oncology is geared towards improving patient care, extending survival, and ultimately curing patients of their cancer by means of innovative cancer therapies. Through The Ottawa Hospital Cancer Centre, the division conducts between 75 and 100 clinical trials for many different types and stages of cancer.
The Division of Oncology is part of the Ottawa Hospital Cancer Centre and provides a wide range of cancer care and services ranging from prevention/screening, through assessment and treatment, to end of life and survivorship care.
The Ottawa Hospital Cancer Program offers cancer services at The Ottawa Hospital Cancer Centre located at TOH’s General Campus and at the Irving Greenberg Family Cancer Centre located at the Queensway Carleton Hospital.